{"id":7963,"date":"2020-10-15T13:56:00","date_gmt":"2020-10-15T13:56:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=7963"},"modified":"2024-05-02T10:20:12","modified_gmt":"2024-05-02T08:20:12","slug":"apheresis-in-inflammatory-bowel-disease-current-evidence-2","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/","title":{"rendered":"Apheresis in Inflammatory Bowel Disease: Current Evidence"},"content":{"rendered":"
\n

Daniel Vasile Balaban and Mariana Jinga Crohn\u2019s Disease Recent Advances<\/a> book, October 15th, 2020 DOI: 10.5772\/intechopen.93605<\/p>\n<\/div>\n\n

\n

Inflammatory bowel diseases (IBD) have become a major focus for gastroenterologists worldwide, with the increasing incidence and complexity of cases, which pose therapeutic challenges. Currently available approaches fail in controlling the disease activity in a significant proportion of patients and some of the therapies are associated with significant adverse events. Although new molecules are on the horizon and treatment strategies have been optimized, novel therapeutic tools are much needed in IBD for patients who fail to attain control of the disease. Apheresis is now a common non-pharmacological therapeutic modality used in several pathologies, IBD also. In the current review, we summarize currently available evidence with respect to selective apheresis in IBD.<\/p>\n<\/div>\n\n

\n

https:\/\/www.intechopen.com\/chapters\/73330<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Daniel Vasile Balaban and Mariana Jinga Crohn\u2019s Disease Recent Advances book, October 15th, 2020 DOI: 10.5772\/intechopen.93605 Inflammatory bowel diseases (IBD) have become a major focus for gastroenterologists worldwide, with the increasing incidence and complexity of cases, which pose therapeutic challenges. Currently available approaches fail in controlling the disease activity in a significant proportion of patients […]<\/p>\n","protected":false},"template":"","scientific_tags":[147,159,157,424,74,173,156,523,55,185,135,306],"class_list":["post-7963","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-clinical-remission","scientific_tags-crohns-disease","scientific_tags-efficacy","scientific_tags-gma","scientific_tags-leukocytapheresis","scientific_tags-moa","scientific_tags-safety","scientific_tags-steroid-tapering","scientific_tags-steroid-dependent","scientific_tags-steroid-naive","scientific_tags-steroid-refractory","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"\nApheresis in Inflammatory Bowel Disease: Current Evidence - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apheresis in Inflammatory Bowel Disease: Current Evidence - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Daniel Vasile Balaban and Mariana Jinga Crohn\u2019s Disease Recent Advances book, October 15th, 2020 DOI: 10.5772\/intechopen.93605 Inflammatory bowel diseases (IBD) have become a major focus for gastroenterologists worldwide, with the increasing incidence and complexity of cases, which pose therapeutic challenges. Currently available approaches fail in controlling the disease activity in a significant proportion of patients […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T08:20:12+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/\",\"name\":\"Apheresis in Inflammatory Bowel Disease: Current Evidence - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2020-10-15T13:56:00+00:00\",\"dateModified\":\"2024-05-02T08:20:12+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Apheresis in Inflammatory Bowel Disease: Current Evidence - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Apheresis in Inflammatory Bowel Disease: Current Evidence - Adacyte","og_description":"Daniel Vasile Balaban and Mariana Jinga Crohn\u2019s Disease Recent Advances book, October 15th, 2020 DOI: 10.5772\/intechopen.93605 Inflammatory bowel diseases (IBD) have become a major focus for gastroenterologists worldwide, with the increasing incidence and complexity of cases, which pose therapeutic challenges. Currently available approaches fail in controlling the disease activity in a significant proportion of patients […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T08:20:12+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/","name":"Apheresis in Inflammatory Bowel Disease: Current Evidence - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2020-10-15T13:56:00+00:00","dateModified":"2024-05-02T08:20:12+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/apheresis-in-inflammatory-bowel-disease-current-evidence-2\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/7963","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=7963"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=7963"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}